Literature DB >> 21600504

Selective propofol injection into the M1 segment of the middle cerebral artery (MCA Wada test) reduces adverse effects and enhances the reliability of the Wada test for determining speech dominance.

Masazumi Fujii1, Shigeru Miyachi, Noriaki Matsubara, Takeshi Kinkori, Shigenori Takebayashi, Takashi Izumi, Tomotaka Ohshima, Arihito Tsurumi, Osamu Hososhima, Toshihiko Wakabayashi, Jun Yoshida.   

Abstract

OBJECT: The Wada test is had been the most reliable for determining speech dominance. Drugs injected into the internal carotid artery, however, may be heterogeneously distributed as the result of asymmetry of the anterior cerebral arteries and the presence of a fetal-type posterior cerebral artery. Variations in drug distribution could occasionally alter consciousness and complicate the evaluation of the test results. We examined selective propofol injection into the M1 segment of the middle cerebral artery (MCA Wada test).
METHODS: For the MCA Wada test (17 patients), 7 or 8 mg of propofol was injected via a microcatheter navigated into the M1 segment, and language function was evaluated by patient performing several tasks. The conventional Wada test (internal carotid artery [ICA] Wada test) was performed in four patients (both the ICA and MCA Wada tests were performed in one patient). The efficacy and adverse effects of both procedures were evaluated; all tests were performed by well-trained interventional neuroradiologists.
RESULTS: Immediately after propofol injection during the MCA Wada test, patients developed transient contralateral hemiplegia and transient aphasia (in the case of injection on the dominant side). Confusion and other severe adverse effects did not occur during the MCA Wada test, but two of four patients who underwent the ICA Wada test showed altered consciousness that affected the performance of the test.
CONCLUSIONS: The MCA Wada test is a feasible and reliable preoperative evaluation, if performed by a trained team of interventional neuroradiologists. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21600504     DOI: 10.1016/j.wneu.2010.10.048

Source DB:  PubMed          Journal:  World Neurosurg        ISSN: 1878-8750            Impact factor:   2.104


  3 in total

1.  Tolerability of propofol in Wada testing.

Authors:  Faisal A Alsallom; Shobhit Sinha; Fahmi M Alsenani; Fawziah A Bamogaddam; Saeed H Wahass; Aurora B Canillo; Khurram A Siddiqui
Journal:  Neurosciences (Riyadh)       Date:  2014-07       Impact factor: 0.906

2.  Noninvasive Prediction of Language Lateralization Through Arcuate Fasciculus Tractography in Patients With Low-Grade Gliomas: Correlation With The Wada Test.

Authors:  Dongdong Wu; Meng Zhang; Jiefeng Geng; Xiaolei Chen
Journal:  Front Oncol       Date:  2022-07-22       Impact factor: 5.738

3.  Determination of language areas in patients with epilepsy using the super-selective Wada test.

Authors:  Kazuo Kakinuma; Shin-Ichiro Osawa; Hiroaki Hosokawa; Marie Oyafuso; Shoko Ota; Erena Kobayashi; Nobuko Kawakami; Kazushi Ukishiro; Kazutaka Jin; Makoto Ishida; Takafumi Sato; Mika Sakamoto; Kuniyasu Niizuma; Teiji Tominaga; Nobukazu Nakasato; Kyoko Suzuki
Journal:  IBRO Neurosci Rep       Date:  2022-08-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.